Search International and National Patent Collections
Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2019032469) TREATMENT OF OVERWEIGHT AND OBESITY ASSOCIATED WITH LEPTIN DEFICIENCY
Latest bibliographic data on file with the International BureauSubmit observation

Pub. No.: WO/2019/032469 International Application No.: PCT/US2018/045425
Publication Date: 14.02.2019 International Filing Date: 06.08.2018
IPC:
A61K 38/22 (2006.01) ,A61K 38/02 (2006.01) ,A23L 33/18 (2016.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
16
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17
from animals; from humans
22
Hormones
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38
Medicinal preparations containing peptides
02
Peptides of undefined number of amino acids; Derivatives thereof
[IPC code unknown for A23L 33/18]
Applicants:
AEGERION PHARMACEUTICALS, INC. [US/US]; One Main Street Suite 800 Cambridge, MA 02142, US
Inventors:
LONG, Alison; US
FINE, Gregory; US
Agent:
GARMAN, Russell, A.; US
Priority Data:
62/542,17507.08.2017US
62/579,81931.10.2017US
Title (EN) TREATMENT OF OVERWEIGHT AND OBESITY ASSOCIATED WITH LEPTIN DEFICIENCY
(FR) TRAITEMENT DU SURPOIDS ET DE L'OBÉSITÉ ASSOCIÉS À UNE DÉFICIENCE EN LEPTINE
Abstract:
(EN) Methods of treating an above-normal weight condition or chronic weight management in a subject with a leptin deficiency involving administration of leptin to the subject. The above-normal weight condition may be overweight or obesity. Further, the subject may also have a weight-related comorbidity, such as hypertension, type 2 diabetes mellitus, or dyslipidemia.
(FR) L'invention concerne des méthodes de traitement d'un état de poids supérieur à la normale ou d'une gestion de poids chronique chez un sujet souffrant d’une déficience en leptine impliquant l'administration de leptine au sujet. L’état de poids supérieur à la normale peut être en surpoids ou en obésité. En outre, le sujet peut également avoir une comorbidité liée au poids (liée au surpoids ou à l’obésité), telle que l'hypertension, le diabète sucré de type 2, ou la dyslipidémie.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)